This is not the most recent version of the article. View current version (8 JUL 2009)

Intervention Protocol

Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer

  1. Philippe Lambin1,*,
  2. Madelon Pijls-Johannesma2,
  3. J de Jong2,
  4. P Van den Ende2,
  5. Dirk K M De Ruysscher2

Editorial Group: Cochrane Ear, Nose and Throat Disorders Group

Published Online: 15 APR 2009

DOI: 10.1002/14651858.CD006158

Database Title

Additional Information

How to Cite

Lambin P, Pijls-Johannesma M, de Jong J, Van den Ende P, De Ruysscher DKM. Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer (Protocol). Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD006158. DOI: 10.1002/14651858.CD006158.

Author Information

  1. 1

    Maastro Clinic, Radiation Oncology, 6020 AZ Maastricht, Netherlands

  2. 2

    Maastro Clinic, Radiation Oncology, Maastricht, Netherlands

*Philippe Lambin, Radiation Oncology, Maastro Clinic, Dr Tanslaan, 12, 6229 ET, Postbus 5800, 6020 AZ Maastricht, Netherlands. Philippe.Lambin@maastro.nl.

Publication History

  1. Publication Status: Unchanged
  2. Published Online: 15 APR 2009

SEARCH

ARTICLE TOOLS

This is not the most recent version of the article.View current version (08 Jul 2009)

View Full Article (HTML) Full (102K)
 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

This systematic review aims to provide a comprehensive and reliable summary of the effects of erythropoietin and radiation therapy in the treatment of head and neck cancer.

The specific aim is to review randomised controlled trials, comparing the effectiveness of concomitant erythropoietin and radiotherapy with radiation therapy alone in the treatment of head and neck cancer.

View Full Article (HTML) Full (102K)